Liberty Mutual launches life sciences insurance solution for middle market companies

Liberty Mutual Insurance Global Risk Solutions launched Liberty Remedy for Life Sciences, a multi-line insurance product designed for middle market life sciences companies.

The offering was developed with input from life sciences companies, agents, and brokers, and includes products liability, clinical trials, errors and omissions, general liability, and umbrella coverage. Liberty said the product is designed to support companies throughout the product lifecycle, from research and development to manufacturing and distribution.

The insurer also introduced optional enhancements tailored to sectors including biologics, medical devices, digital health, dietary supplements, clinical trials, veterinary products, and contract research organizations.

“When we made the investment to build a market-leading Life Sciences practice, our mission was clear. We worked from the outside in — through the lens of the Life Sciences community we serve — to become the partner of choice for the full spectrum of insurance and risk management solutions this dynamic industry expects and needs. Liberty Remedy reflects that commitment to partnership — on both offense and defense — helping clients proactively mitigate risk, address complex challenges, and deliver strong protection when it matters most.” – Tory Agnich, Liberty Mutual chief underwriting officer, GRS Middle Market Life Sciences.

“Life Sciences claims are among the most complex in today’s risk landscape, often involving scientific questions, regulatory scrutiny, operational disruption, and significant business pressure simultaneously. By integrating deep technical expertise with disciplined claims oversight, we enable clients to respond decisively and navigate critical moments with clarity, speed, and confidence.” – Megan Kriegstein, Vice President, GRS Life Sciences Claims.